Retatrutide · Dallas, TX

The next generation
of weight loss is here.

Retatrutide is a triple receptor agonist — activating GLP-1, GIP, and glucagon pathways simultaneously. For patients who need more than the standard GLP-1 can offer.

Three pathways.
One medication.

Where semaglutide targets one receptor and tirzepatide targets two, retatrutide activates three. The clinical data is striking — and we're now offering it to the right candidates.

What makes retatrutide different

Triple Receptor Action
GLP-1 + GIP + glucagon receptor agonism. Each pathway adds a distinct metabolic effect.
Exceptional Weight Loss Data
Phase 2 trials showed up to 24% body weight reduction at highest doses — more than any prior GLP-1.
Weekly Injection
Same delivery format as semaglutide and tirzepatide. Subcutaneous self-injection, once per week.
For Appropriate Candidates
We prescribe retatrutide selectively. A thorough consultation determines whether it's right for you.
Physician-Supervised Protocol
Labs, monitoring, dose titration, and follow-up. The medication is powerful — the oversight matches it.

Is retatrutide
right for you?

01A consultation to review your history with GLP-1s, your goals, and your labs.
02A physician assessment to determine candidacy and starting dose.
03A structured protocol with regular monitoring and honest communication about results.

We don't prescribe it because it's new. We prescribe it when it's the right fit.

Ask us about
retatrutide.

Next-generation weight loss · Dallas, TX · Physician-guided

Book a Consultation

Consultations are a conversation. No commitment required.

The next generationof weight loss is here.

Three pathways.One medication.

Triple Receptor Action

Exceptional Weight Loss Data

Weekly Injection

For Appropriate Candidates

Physician-Supervised Protocol

Is retatrutideright for you?

Ask us aboutretatrutide.

The next generation
of weight loss is here.

Three pathways.
One medication.

Is retatrutide
right for you?

Ask us about
retatrutide.